ERAS-5

N/A

Report date: 2021/12/07 13:29:05
NME

Base Information

Drug NameERAS-5
Drug Alias NameERAS-5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAutophagy-related protein-1 homolog inhibitorsUnc-51 Like Autophagy Activating Kinase 2 inhibitors
TargetsAutophagy-related protein-1 homologUnc-51 Like Autophagy Activating Kinase 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLifearc
China Registration ClassN/A

Develop Information

Active CompaniesErasca Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A